London
· Delayed Price · Currency is GBP · Price in GBXFutura Medical Statistics
Total Valuation
Futura Medical has a market cap or net worth of GBP 100.62 million. The enterprise value is 96.70 million.
| Market Cap | 100.62M |
| Enterprise Value | 96.70M |
Important Dates
The next estimated earnings date is Wednesday, December 11, 2024.
| Earnings Date | Dec 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Futura Medical has 302.40 million shares outstanding. The number of shares has increased by 4.46% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 302.40M |
| Shares Change (YoY) | +4.46% |
| Shares Change (QoQ) | +5.51% |
| Owned by Insiders (%) | 10.33% |
| Owned by Institutions (%) | 56.80% |
| Float | 255.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 220.36 |
| PS Ratio | 11.93 |
| PB Ratio | 12.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -25.77 |
| EV / Sales | 11.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -22.94 |
Financial Position
The company has a current ratio of 3.75
| Current Ratio | 3.75 |
| Quick Ratio | 3.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.43% and return on invested capital (ROIC) is -33.07%.
| Return on Equity (ROE) | -47.43% |
| Return on Assets (ROA) | -26.59% |
| Return on Capital (ROIC) | -33.07% |
| Revenue Per Employee | 699,851 |
| Profits Per Employee | -312,682 |
| Employee Count | 12 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 5,722.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.89% |
| 50-Day Moving Average | 35.16 |
| 200-Day Moving Average | 37.01 |
| Relative Strength Index (RSI) | 37.75 |
| Average Volume (20 Days) | 940,374 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Futura Medical had revenue of GBP 8.40 million and -3.75 million in losses. Loss per share was -0.01.
| Revenue | 8.40M |
| Gross Profit | 5.69M |
| Operating Income | -4.18M |
| Pretax Income | -4.07M |
| Net Income | -3.75M |
| EBITDA | -4.06M |
| EBIT | -4.18M |
| Loss Per Share | -0.01 |
Balance Sheet
| Cash & Cash Equivalents | 3.92M |
| Total Debt | n/a |
| Net Cash | 3.92M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 7.81M |
| Book Value Per Share | 0.03 |
| Working Capital | 4.56M |
Cash Flow
In the last 12 months, operating cash flow was -1.89 million and capital expenditures -2.32 million, giving a free cash flow of -4.22 million.
| Operating Cash Flow | -1.89M |
| Capital Expenditures | -2.32M |
| Free Cash Flow | -4.22M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 67.70%, with operating and profit margins of -49.83% and -44.68%.
| Gross Margin | 67.70% |
| Operating Margin | -49.83% |
| Pretax Margin | -48.42% |
| Profit Margin | -44.68% |
| EBITDA Margin | -48.35% |
| EBIT Margin | -49.83% |
| FCF Margin | -50.20% |
Dividends & Yields
Futura Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.46% |
| Shareholder Yield | -4.46% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Futura Medical has an Altman Z-Score of 33.61.
| Altman Z-Score | 33.61 |
| Piotroski F-Score | n/a |